Keeping pace with new technologies: systems needed to identify and evaluate them

Of the three major pressures on health services worldwide—changing demography, growing expectations, and new healthcare interventions (technologies) —the last is generating the most concern and the most dramatic responses. New healthcare technologies are becoming more numerous, more expensive, and possibly more effective than ever before. About 50 new drugs are launched each year, and the number of new devices, procedures, and ways of providing care is growing all the time. #### Summary points New and changing technologies are a major pressure on health services, challenging cost control and research capacity The NHS system to identify and evaluate new technologies and select the most important ones for assessment needs to develop a range of suitable research methods and the means to disseminate knowledge and implement the technologies A pragmatic research solution is evolving, with rapid reviews, modelling, economic evaluation, and pragmatic trials as well as the mainstream efficacy trials and Cochrane reviews Closer contact between research managers and the research team and new tools such as tracker trials may need to be developed too Not only is there a challenge in relation to cost control, but, more compellingly, in relation to determining effectiveness.1 For example, it is often not clear: Without this information there is a risk of distorted priorities as political pressure to keep a lid on budgets creates a tension between the claims of different technologies for part of the public purse. In 1992 the Advisory Group on Health Technology Assessment suggested that the “costs of providing unevaluated new forms of care within the NHS should be met only if they are being offered within the …

[1]  A Stevens,et al.  WHAT ARE THE RELATIVE MERITS OF THE SOURCES USED TO IDENTIFY POTENTIAL RESEARCH PRIORITIES FOR THE NHS HTA PROGRAMME? , 2000, International Journal of Technology Assessment in Health Care.

[2]  M. Drummond,et al.  The Iterative Use of Economic Evaluation as Part of the Process of Health Technology Assessment , 1997, Journal of health services research & policy.

[3]  H. Beppu,et al.  Donepezil for mild and moderate Alzheimer's disease. , 2000 .

[4]  Steve Hanney,et al.  How Can Payback from Health Services Research Be Assessed? , 1996, Journal of health services research & policy.

[5]  A. Stevens,et al.  'Quick and clean': authoritative health technology assessment for local health care contracting. , 1995, Health trends.

[6]  R J Lilford,et al.  Trials and fast changing technologies: the case for tracker studies , 2000, BMJ : British Medical Journal.

[7]  D M Eddy,et al.  Selecting Technologies for Assessment , 1989, International Journal of Technology Assessment in Health Care.

[8]  Sox Hc,et al.  Setting Priorities for Health Technology Assessment: A Model Process , 1992 .

[9]  R N Battista,et al.  Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination. , 1990, Journal of clinical epidemiology.

[10]  Linking health technology assessment to practice , 1999 .

[11]  R Lilford,et al.  Commissioning Health Services Research: An Iterative Method , 1999, Journal of health services research & policy.

[12]  R Lilford,et al.  Decision Analysis in the Selection, Design and Application of Clinical and Health Services Research , 1998, Journal of health services research & policy.